The incidence of TFE3 translocation renal carcinoma among adult patients

被引：0
|
作者：
Higa, B. [1 ]
Flanigan, R. C. [1 ]
Picken, M. M. [1 ]
机构：
[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
733
引用
收藏
页码：161A / 161A
页数：1
相关论文
共 50 条
  • [21] Clinicopathological and prognostic significance of TFE3 in papillary renal carcinoma
    Takamatsu, T.
    Kenichi, K.
    Daisuke, K.
    Fumio, K.
    Masaki, S.
    Yoshinao, O.
    Masatoshi, E.
    EUROPEAN UROLOGY, 2021, 79 : S738 - S738
  • [22] Renal Cancer Without Primary Cancer in the Kidney: Extra-Renal TFE3 Translocation Associated Renal Cell Carcinoma
    Petrinec, Benjamin
    Vargas, Bryan Morales
    Harik, Lara R.
    Master, Viraj A.
    KIDNEY CANCER, 2021, 5 (02) : 107 - 112
  • [23] Hibernoma-like Changes and TFE3 Expression in Mesothelioma Mimicking TFE3-Translocation Renal Cell Carcinoma: A Diagnostic Pitfall
    Hoton, Delphine
    Luyckx, Mathieu
    Galant, Christine
    Dano, Helene
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2021, 29 (06) : 627 - 630
  • [24] Imaging findings, clinical and pathological characters of 28 patients with Xp11.2/TFE3 translocation renal cell carcinoma
    Dong, Haiping
    Ni, Yang
    Liu, Zhiling
    Wang, Zhou
    Hu, Bo
    Xu, Hongzhi
    Cai, Shifeng
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (01) : 132 - 140
  • [25] Xp11.2/TFE3 translocation tumors are infrequent in unselected sporadic renal cell carcinoma (RCC) in young patients
    Hammerschmied, C.
    Denzinger, S.
    Argani, P.
    Otto, W.
    Blaszyk, H.
    Walter, B.
    Hartmann, A.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 311 - 311
  • [26] Imprint Cytologic Features in Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion in an Adult A Case Report
    Yamaguchi, Tadanori
    Kuroda, Naoto
    Imamura, Yoshiaki
    Hes, Ondrej
    Kawada, Takako
    Nakayama, Keizou
    ACTA CYTOLOGICA, 2009, 53 (06) : 693 - 697
  • [27] CHARACTERIZATION OF CHIMERIC TFE3 TRANSCRIPTION FACTORS FOUND IN XP11.2 TRANSLOCATION RENAL CELL CARCINOMA
    Motoshima, Takanobu
    Satou, Yorifumi
    Miyazato, Paola
    Hasumi, Hisashi
    Huang, Ying
    Kadomatsu, Tsuyoshi
    Yao, Masahiro
    Nagashima, Yoji
    Furuya, Mitsuko
    Oike, Yuchi
    Schmidt, Laura S.
    Kamba, Tomomi
    Linehan, W. Marston
    Baba, Masaya
    JOURNAL OF UROLOGY, 2018, 199 (04): : E895 - E895
  • [28] TFE3 expression in renal cell carcinoma is correlated with poor prognosis regardless of its gene translocation status
    Lee, Hyun Jung
    Shin, Dong Hoon
    Young, Kim So
    Hwang, Chung Su
    Keum, Kim Young
    Kim, Ahrong
    Park, Won Young
    Hee, Lee Jung
    Kim, Jee Yeon
    LABORATORY INVESTIGATION, 2018, 98 : 358 - 359
  • [29] Targeting the TFE3 pathway in translocation renal cell carcinoma with the antibody-drug conjugate Glembatumumab vedotin
    Lang, M.
    Wei, D.
    Gibbs, B. K.
    Ohanjanian, L.
    Ricketts, C. J.
    Sourbier, C.
    Schmidt, L. S.
    Linehan, W. M.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E132 - E132
  • [30] TFE3 expression in renal cell carcinoma is correlated with poor prognosis regardless of its gene translocation status
    Lee, Hyun Jung
    Shin, Dong Hoon
    Young, Kim So
    Hwang, Chung Su
    Keum, Kim Young
    Kim, Ahrong
    Park, Won Young
    Hee, Lee Jung
    Kim, Jee Yeon
    MODERN PATHOLOGY, 2018, 31 : 358 - 359
12345